Compare SEM & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEM | PAHC |
|---|---|---|
| Founded | 1996 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2009 | 2014 |
| Metric | SEM | PAHC |
|---|---|---|
| Price | $14.89 | $37.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $16.33 | ★ $31.25 |
| AVG Volume (30 Days) | ★ 979.3K | 270.7K |
| Earning Date | 02-19-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.68% | 1.28% |
| EPS Growth | N/A | ★ 288.74 |
| EPS | 0.87 | ★ 1.67 |
| Revenue | ★ $5,368,760,000.00 | $1,399,676,000.00 |
| Revenue This Year | $5.53 | $15.34 |
| Revenue Next Year | $4.33 | $3.28 |
| P/E Ratio | ★ $19.54 | $22.36 |
| Revenue Growth | ★ 45.29 | 33.72 |
| 52 Week Low | $11.65 | $16.16 |
| 52 Week High | $20.83 | $46.42 |
| Indicator | SEM | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.32 | 38.85 |
| Support Level | $14.73 | $37.05 |
| Resistance Level | $15.18 | $38.49 |
| Average True Range (ATR) | 0.30 | 1.39 |
| MACD | -0.08 | -0.17 |
| Stochastic Oscillator | 20.64 | 22.74 |
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.